ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Premenstrual Syndrome Treatment Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-8E13636
Home | Market Reports | Health| Reproductive Health
Global Premenstrual Syndrome Treatment Market Research Report 2023
BUY CHAPTERS

Global Premenstrual Syndrome Treatment Market Research Report 2025

Code: QYRE-Auto-8E13636
Report
May 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Astrazeneca plc
BASF Corporation
Bayer
Eli Lilly and Company
GlaxoSmithKline PLC
Pfizer Inc
Shionogi
Johnson & Johnson
Novartis
Merck& Co. Inc
Allergan plc
Mylan N.V.

Premenstrual Syndrome Treatment Market Size

The global market for Premenstrual Syndrome Treatment was valued at US$ 1402 million in the year 2024 and is projected to reach a revised size of US$ 1765 million by 2031, growing at a CAGR of 3.4% during the forecast period.

Premenstrual Syndrome Treatment Market

Premenstrual Syndrome Treatment Market

Premenstrual syndrome or PMS is a group of physical and emotional symptoms many women may have in the days before their period starts. Symptoms usually stop once the period starts. It’s thought to be related to the changing hormone levels of the menstrual cycle.Lifestyle changes and sometimes medicine are used to treat PMS.
The global premenstrual syndrome (PMS) treatment market refers to the market for various products and therapies aimed at managing the symptoms associated with PMS. PMS refers to a combination of physical, emotional, and behavioral symptoms experienced by women in the days leading up to their menstrual period.
The market for PMS treatment is influenced by the growing awareness and recognition of PMS as a medical condition, the increasing number of women seeking medical assistance for PMS symptoms, and the development of new treatment options. Here are some key factors and trends in the global PMS treatment market:
Product Types: The PMS treatment market offers a range of products, including medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), hormonal contraceptives, antidepressants, and diuretics. Alternative therapies like herbal remedies, nutritional supplements, and lifestyle modifications are also popular.
Hormonal Contraceptives: Hormonal contraceptives, such as oral contraceptives and intrauterine devices (IUDs), are commonly prescribed for managing PMS symptoms. These contraceptives help regulate hormone levels and reduce symptoms like mood swings, pain, and bloating.
Antidepressants: Certain antidepressant medications, particularly selective serotonin reuptake inhibitors (SSRIs), are often prescribed to alleviate the emotional symptoms associated with PMS, including irritability, depression, and anxiety.
Herbal Remedies and Nutritional Supplements: There is a growing demand for natural and holistic approaches to managing PMS symptoms. Herbal remedies like chasteberry, evening primrose oil, and black cohosh, as well as nutritional supplements like calcium, magnesium, and vitamin B6, are commonly used for symptom relief.
Awareness and Education: Increasing efforts to raise awareness about PMS and its impact on women’s health are leading to improved recognition and diagnosis of the condition. This awareness is driving the demand for effective treatment options and encouraging more women to seek medical help.
Online Platforms and Apps: The availability of online platforms and mobile applications focused on women’s health is helping to educate and empower women in managing their PMS symptoms. These platforms provide information, symptom tracking tools, and community support.
Research and Development: The PMS treatment market is witnessing ongoing research and development activities to explore new treatment options, including innovative drug therapies, herbal formulations, and personalized medicine approaches.
Regional Market: The PMS treatment market varies across regions due to differences in healthcare infrastructure, cultural beliefs, and access to medical services. North America and Europe are expected to dominate the global market due to higher awareness and healthcare expenditure, while Asia Pacific is projected to exhibit significant growth due to rising healthcare awareness and improving access to healthcare.The global premenstrual syndrome (PMS) treatment market refers to the market for various products and therapies aimed at managing the symptoms associated with PMS. PMS refers to a combination of physical, emotional, and behavioral symptoms experienced by women in the days leading up to their menstrual period.
The market for PMS treatment is influenced by the growing awareness and recognition of PMS as a medical condition, the increasing number of women seeking medical assistance for PMS symptoms, and the development of new treatment options. Here are some key factors and trends in the global PMS treatment market:
Product Types: The PMS treatment market offers a range of products, including medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), hormonal contraceptives, antidepressants, and diuretics. Alternative therapies like herbal remedies, nutritional supplements, and lifestyle modifications are also popular.
Hormonal Contraceptives: Hormonal contraceptives, such as oral contraceptives and intrauterine devices (IUDs), are commonly prescribed for managing PMS symptoms. These contraceptives help regulate hormone levels and reduce symptoms like mood swings, pain, and bloating.
Antidepressants: Certain antidepressant medications, particularly selective serotonin reuptake inhibitors (SSRIs), are often prescribed to alleviate the emotional symptoms associated with PMS, including irritability, depression, and anxiety.
Herbal Remedies and Nutritional Supplements: There is a growing demand for natural and holistic approaches to managing PMS symptoms. Herbal remedies like chasteberry, evening primrose oil, and black cohosh, as well as nutritional supplements like calcium, magnesium, and vitamin B6, are commonly used for symptom relief.
Awareness and Education: Increasing efforts to raise awareness about PMS and its impact on women’s health are leading to improved recognition and diagnosis of the condition. This awareness is driving the demand for effective treatment options and encouraging more women to seek medical help.
Online Platforms and Apps: The availability of online platforms and mobile applications focused on women’s health is helping to educate and empower women in managing their PMS symptoms. These platforms provide information, symptom tracking tools, and community support.
Research and Development: The PMS treatment market is witnessing ongoing research and development activities to explore new treatment options, including innovative drug therapies, herbal formulations, and personalized medicine approaches.
Regional Market: The PMS treatment market varies across regions due to differences in healthcare infrastructure, cultural beliefs, and access to medical services. North America and Europe are expected to dominate the global market due to higher awareness and healthcare expenditure, while Asia Pacific is projected to exhibit significant growth due to rising healthcare awareness and improving access to healthcare.
This report aims to provide a comprehensive presentation of the global market for Premenstrual Syndrome Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Premenstrual Syndrome Treatment.
The Premenstrual Syndrome Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Premenstrual Syndrome Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Premenstrual Syndrome Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Premenstrual Syndrome Treatment Market Report

Report Metric Details
Report Name Premenstrual Syndrome Treatment Market
Accounted market size in year US$ 1402 million
Forecasted market size in 2031 US$ 1765 million
CAGR 3.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Younger than 20 Years
  • 20-40 Years Old Adults
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie, AstraZeneca, BASF Corporation, Bayer, Eli Lilly And Company, GlaxoSmithKline, Pfizer, Shionogi, Johnson & Johnson, Novartis AG, Merck & Co., Inc., Allergan plc, Mylan N.V.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Premenstrual Syndrome Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Premenstrual Syndrome Treatment Market growing?

Ans: The Premenstrual Syndrome Treatment Market witnessing a CAGR of 3.4% during the forecast period 2025-2031.

What is the Premenstrual Syndrome Treatment Market size in 2031?

Ans: The Premenstrual Syndrome Treatment Market size in 2031 will be US$ 1765 million.

Who are the main players in the Premenstrual Syndrome Treatment Market report?

Ans: The main players in the Premenstrual Syndrome Treatment Market are AbbVie, AstraZeneca, BASF Corporation, Bayer, Eli Lilly And Company, GlaxoSmithKline, Pfizer, Shionogi, Johnson & Johnson, Novartis AG, Merck & Co., Inc., Allergan plc, Mylan N.V.

What are the Application segmentation covered in the Premenstrual Syndrome Treatment Market report?

Ans: The Applications covered in the Premenstrual Syndrome Treatment Market report are Younger than 20 Years, 20-40 Years Old Adults

What are the Type segmentation covered in the Premenstrual Syndrome Treatment Market report?

Ans: The Types covered in the Premenstrual Syndrome Treatment Market report are Medication, Dietary Treatment, Emotional Treatment, Hormone Therapy, Others

Recommended Reports

Women’s Health Therapies

Hormonal and Fertility

Mental Health Medications

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Premenstrual Syndrome Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Medication
1.2.3 Dietary Treatment
1.2.4 Emotional Treatment
1.2.5 Hormone Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Premenstrual Syndrome Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Younger than 20 Years
1.3.3 20-40 Years Old Adults
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Premenstrual Syndrome Treatment Market Perspective (2020-2031)
2.2 Global Premenstrual Syndrome Treatment Growth Trends by Region
2.2.1 Global Premenstrual Syndrome Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Premenstrual Syndrome Treatment Historic Market Size by Region (2020-2025)
2.2.3 Premenstrual Syndrome Treatment Forecasted Market Size by Region (2026-2031)
2.3 Premenstrual Syndrome Treatment Market Dynamics
2.3.1 Premenstrual Syndrome Treatment Industry Trends
2.3.2 Premenstrual Syndrome Treatment Market Drivers
2.3.3 Premenstrual Syndrome Treatment Market Challenges
2.3.4 Premenstrual Syndrome Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Premenstrual Syndrome Treatment Players by Revenue
3.1.1 Global Top Premenstrual Syndrome Treatment Players by Revenue (2020-2025)
3.1.2 Global Premenstrual Syndrome Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Premenstrual Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Premenstrual Syndrome Treatment Revenue
3.4 Global Premenstrual Syndrome Treatment Market Concentration Ratio
3.4.1 Global Premenstrual Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Premenstrual Syndrome Treatment Revenue in 2024
3.5 Global Key Players of Premenstrual Syndrome Treatment Head office and Area Served
3.6 Global Key Players of Premenstrual Syndrome Treatment, Product and Application
3.7 Global Key Players of Premenstrual Syndrome Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Premenstrual Syndrome Treatment Breakdown Data by Type
4.1 Global Premenstrual Syndrome Treatment Historic Market Size by Type (2020-2025)
4.2 Global Premenstrual Syndrome Treatment Forecasted Market Size by Type (2026-2031)
5 Premenstrual Syndrome Treatment Breakdown Data by Application
5.1 Global Premenstrual Syndrome Treatment Historic Market Size by Application (2020-2025)
5.2 Global Premenstrual Syndrome Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Premenstrual Syndrome Treatment Market Size (2020-2031)
6.2 North America Premenstrual Syndrome Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Premenstrual Syndrome Treatment Market Size by Country (2020-2025)
6.4 North America Premenstrual Syndrome Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Premenstrual Syndrome Treatment Market Size (2020-2031)
7.2 Europe Premenstrual Syndrome Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Premenstrual Syndrome Treatment Market Size by Country (2020-2025)
7.4 Europe Premenstrual Syndrome Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Premenstrual Syndrome Treatment Market Size (2020-2031)
8.2 Asia-Pacific Premenstrual Syndrome Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Premenstrual Syndrome Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Premenstrual Syndrome Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Premenstrual Syndrome Treatment Market Size (2020-2031)
9.2 Latin America Premenstrual Syndrome Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Premenstrual Syndrome Treatment Market Size by Country (2020-2025)
9.4 Latin America Premenstrual Syndrome Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Premenstrual Syndrome Treatment Market Size (2020-2031)
10.2 Middle East & Africa Premenstrual Syndrome Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Premenstrual Syndrome Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Premenstrual Syndrome Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Premenstrual Syndrome Treatment Introduction
11.1.4 AbbVie Revenue in Premenstrual Syndrome Treatment Business (2020-2025)
11.1.5 AbbVie Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Premenstrual Syndrome Treatment Introduction
11.2.4 AstraZeneca Revenue in Premenstrual Syndrome Treatment Business (2020-2025)
11.2.5 AstraZeneca Recent Development
11.3 BASF Corporation
11.3.1 BASF Corporation Company Details
11.3.2 BASF Corporation Business Overview
11.3.3 BASF Corporation Premenstrual Syndrome Treatment Introduction
11.3.4 BASF Corporation Revenue in Premenstrual Syndrome Treatment Business (2020-2025)
11.3.5 BASF Corporation Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Premenstrual Syndrome Treatment Introduction
11.4.4 Bayer Revenue in Premenstrual Syndrome Treatment Business (2020-2025)
11.4.5 Bayer Recent Development
11.5 Eli Lilly And Company
11.5.1 Eli Lilly And Company Company Details
11.5.2 Eli Lilly And Company Business Overview
11.5.3 Eli Lilly And Company Premenstrual Syndrome Treatment Introduction
11.5.4 Eli Lilly And Company Revenue in Premenstrual Syndrome Treatment Business (2020-2025)
11.5.5 Eli Lilly And Company Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Premenstrual Syndrome Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Premenstrual Syndrome Treatment Business (2020-2025)
11.6.5 GlaxoSmithKline Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Premenstrual Syndrome Treatment Introduction
11.7.4 Pfizer Revenue in Premenstrual Syndrome Treatment Business (2020-2025)
11.7.5 Pfizer Recent Development
11.8 Shionogi
11.8.1 Shionogi Company Details
11.8.2 Shionogi Business Overview
11.8.3 Shionogi Premenstrual Syndrome Treatment Introduction
11.8.4 Shionogi Revenue in Premenstrual Syndrome Treatment Business (2020-2025)
11.8.5 Shionogi Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Details
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Premenstrual Syndrome Treatment Introduction
11.9.4 Johnson & Johnson Revenue in Premenstrual Syndrome Treatment Business (2020-2025)
11.9.5 Johnson & Johnson Recent Development
11.10 Novartis AG
11.10.1 Novartis AG Company Details
11.10.2 Novartis AG Business Overview
11.10.3 Novartis AG Premenstrual Syndrome Treatment Introduction
11.10.4 Novartis AG Revenue in Premenstrual Syndrome Treatment Business (2020-2025)
11.10.5 Novartis AG Recent Development
11.11 Merck & Co., Inc.
11.11.1 Merck & Co., Inc. Company Details
11.11.2 Merck & Co., Inc. Business Overview
11.11.3 Merck & Co., Inc. Premenstrual Syndrome Treatment Introduction
11.11.4 Merck & Co., Inc. Revenue in Premenstrual Syndrome Treatment Business (2020-2025)
11.11.5 Merck & Co., Inc. Recent Development
11.12 Allergan plc
11.12.1 Allergan plc Company Details
11.12.2 Allergan plc Business Overview
11.12.3 Allergan plc Premenstrual Syndrome Treatment Introduction
11.12.4 Allergan plc Revenue in Premenstrual Syndrome Treatment Business (2020-2025)
11.12.5 Allergan plc Recent Development
11.13 Mylan N.V.
11.13.1 Mylan N.V. Company Details
11.13.2 Mylan N.V. Business Overview
11.13.3 Mylan N.V. Premenstrual Syndrome Treatment Introduction
11.13.4 Mylan N.V. Revenue in Premenstrual Syndrome Treatment Business (2020-2025)
11.13.5 Mylan N.V. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
AbbVie
Astrazeneca plc
BASF Corporation
Bayer
Eli Lilly and Company
GlaxoSmithKline PLC
Pfizer Inc
Shionogi
Johnson & Johnson
Novartis
Merck& Co. Inc
Allergan plc
Mylan N.V.
List of Tables
 Table 1. Global Premenstrual Syndrome Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Medication
 Table 3. Key Players of Dietary Treatment
 Table 4. Key Players of Emotional Treatment
 Table 5. Key Players of Hormone Therapy
 Table 6. Key Players of Others
 Table 7. Global Premenstrual Syndrome Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Premenstrual Syndrome Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Premenstrual Syndrome Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Premenstrual Syndrome Treatment Market Share by Region (2020-2025)
 Table 11. Global Premenstrual Syndrome Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Premenstrual Syndrome Treatment Market Share by Region (2026-2031)
 Table 13. Premenstrual Syndrome Treatment Market Trends
 Table 14. Premenstrual Syndrome Treatment Market Drivers
 Table 15. Premenstrual Syndrome Treatment Market Challenges
 Table 16. Premenstrual Syndrome Treatment Market Restraints
 Table 17. Global Premenstrual Syndrome Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Premenstrual Syndrome Treatment Market Share by Players (2020-2025)
 Table 19. Global Top Premenstrual Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Premenstrual Syndrome Treatment as of 2024)
 Table 20. Ranking of Global Top Premenstrual Syndrome Treatment Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Premenstrual Syndrome Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Premenstrual Syndrome Treatment, Headquarters and Area Served
 Table 23. Global Key Players of Premenstrual Syndrome Treatment, Product and Application
 Table 24. Global Key Players of Premenstrual Syndrome Treatment, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Premenstrual Syndrome Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Premenstrual Syndrome Treatment Revenue Market Share by Type (2020-2025)
 Table 28. Global Premenstrual Syndrome Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Premenstrual Syndrome Treatment Revenue Market Share by Type (2026-2031)
 Table 30. Global Premenstrual Syndrome Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Premenstrual Syndrome Treatment Revenue Market Share by Application (2020-2025)
 Table 32. Global Premenstrual Syndrome Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Premenstrual Syndrome Treatment Revenue Market Share by Application (2026-2031)
 Table 34. North America Premenstrual Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Premenstrual Syndrome Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Premenstrual Syndrome Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Premenstrual Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Premenstrual Syndrome Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Premenstrual Syndrome Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Premenstrual Syndrome Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Premenstrual Syndrome Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Premenstrual Syndrome Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Premenstrual Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Premenstrual Syndrome Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Premenstrual Syndrome Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Premenstrual Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Premenstrual Syndrome Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Premenstrual Syndrome Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 49. AbbVie Company Details
 Table 50. AbbVie Business Overview
 Table 51. AbbVie Premenstrual Syndrome Treatment Product
 Table 52. AbbVie Revenue in Premenstrual Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 53. AbbVie Recent Development
 Table 54. AstraZeneca Company Details
 Table 55. AstraZeneca Business Overview
 Table 56. AstraZeneca Premenstrual Syndrome Treatment Product
 Table 57. AstraZeneca Revenue in Premenstrual Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 58. AstraZeneca Recent Development
 Table 59. BASF Corporation Company Details
 Table 60. BASF Corporation Business Overview
 Table 61. BASF Corporation Premenstrual Syndrome Treatment Product
 Table 62. BASF Corporation Revenue in Premenstrual Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 63. BASF Corporation Recent Development
 Table 64. Bayer Company Details
 Table 65. Bayer Business Overview
 Table 66. Bayer Premenstrual Syndrome Treatment Product
 Table 67. Bayer Revenue in Premenstrual Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 68. Bayer Recent Development
 Table 69. Eli Lilly And Company Company Details
 Table 70. Eli Lilly And Company Business Overview
 Table 71. Eli Lilly And Company Premenstrual Syndrome Treatment Product
 Table 72. Eli Lilly And Company Revenue in Premenstrual Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 73. Eli Lilly And Company Recent Development
 Table 74. GlaxoSmithKline Company Details
 Table 75. GlaxoSmithKline Business Overview
 Table 76. GlaxoSmithKline Premenstrual Syndrome Treatment Product
 Table 77. GlaxoSmithKline Revenue in Premenstrual Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 78. GlaxoSmithKline Recent Development
 Table 79. Pfizer Company Details
 Table 80. Pfizer Business Overview
 Table 81. Pfizer Premenstrual Syndrome Treatment Product
 Table 82. Pfizer Revenue in Premenstrual Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 83. Pfizer Recent Development
 Table 84. Shionogi Company Details
 Table 85. Shionogi Business Overview
 Table 86. Shionogi Premenstrual Syndrome Treatment Product
 Table 87. Shionogi Revenue in Premenstrual Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 88. Shionogi Recent Development
 Table 89. Johnson & Johnson Company Details
 Table 90. Johnson & Johnson Business Overview
 Table 91. Johnson & Johnson Premenstrual Syndrome Treatment Product
 Table 92. Johnson & Johnson Revenue in Premenstrual Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 93. Johnson & Johnson Recent Development
 Table 94. Novartis AG Company Details
 Table 95. Novartis AG Business Overview
 Table 96. Novartis AG Premenstrual Syndrome Treatment Product
 Table 97. Novartis AG Revenue in Premenstrual Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 98. Novartis AG Recent Development
 Table 99. Merck & Co., Inc. Company Details
 Table 100. Merck & Co., Inc. Business Overview
 Table 101. Merck & Co., Inc. Premenstrual Syndrome Treatment Product
 Table 102. Merck & Co., Inc. Revenue in Premenstrual Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 103. Merck & Co., Inc. Recent Development
 Table 104. Allergan plc Company Details
 Table 105. Allergan plc Business Overview
 Table 106. Allergan plc Premenstrual Syndrome Treatment Product
 Table 107. Allergan plc Revenue in Premenstrual Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 108. Allergan plc Recent Development
 Table 109. Mylan N.V. Company Details
 Table 110. Mylan N.V. Business Overview
 Table 111. Mylan N.V. Premenstrual Syndrome Treatment Product
 Table 112. Mylan N.V. Revenue in Premenstrual Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 113. Mylan N.V. Recent Development
 Table 114. Research Programs/Design for This Report
 Table 115. Key Data Information from Secondary Sources
 Table 116. Key Data Information from Primary Sources
 Table 117. Authors List of This Report


List of Figures
 Figure 1. Premenstrual Syndrome Treatment Picture
 Figure 2. Global Premenstrual Syndrome Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Premenstrual Syndrome Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Medication Features
 Figure 5. Dietary Treatment Features
 Figure 6. Emotional Treatment Features
 Figure 7. Hormone Therapy Features
 Figure 8. Others Features
 Figure 9. Global Premenstrual Syndrome Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Premenstrual Syndrome Treatment Market Share by Application: 2024 VS 2031
 Figure 11. Younger than 20 Years Case Studies
 Figure 12. 20-40 Years Old Adults Case Studies
 Figure 13. Premenstrual Syndrome Treatment Report Years Considered
 Figure 14. Global Premenstrual Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Premenstrual Syndrome Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Premenstrual Syndrome Treatment Market Share by Region: 2024 VS 2031
 Figure 17. Global Premenstrual Syndrome Treatment Market Share by Players in 2024
 Figure 18. Global Top Premenstrual Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Premenstrual Syndrome Treatment as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Premenstrual Syndrome Treatment Revenue in 2024
 Figure 20. North America Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Premenstrual Syndrome Treatment Market Share by Country (2020-2031)
 Figure 22. United States Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Premenstrual Syndrome Treatment Market Share by Country (2020-2031)
 Figure 26. Germany Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Premenstrual Syndrome Treatment Market Share by Region (2020-2031)
 Figure 34. China Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Premenstrual Syndrome Treatment Market Share by Country (2020-2031)
 Figure 42. Mexico Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Premenstrual Syndrome Treatment Market Share by Country (2020-2031)
 Figure 46. Turkey Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Premenstrual Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. AbbVie Revenue Growth Rate in Premenstrual Syndrome Treatment Business (2020-2025)
 Figure 50. AstraZeneca Revenue Growth Rate in Premenstrual Syndrome Treatment Business (2020-2025)
 Figure 51. BASF Corporation Revenue Growth Rate in Premenstrual Syndrome Treatment Business (2020-2025)
 Figure 52. Bayer Revenue Growth Rate in Premenstrual Syndrome Treatment Business (2020-2025)
 Figure 53. Eli Lilly And Company Revenue Growth Rate in Premenstrual Syndrome Treatment Business (2020-2025)
 Figure 54. GlaxoSmithKline Revenue Growth Rate in Premenstrual Syndrome Treatment Business (2020-2025)
 Figure 55. Pfizer Revenue Growth Rate in Premenstrual Syndrome Treatment Business (2020-2025)
 Figure 56. Shionogi Revenue Growth Rate in Premenstrual Syndrome Treatment Business (2020-2025)
 Figure 57. Johnson & Johnson Revenue Growth Rate in Premenstrual Syndrome Treatment Business (2020-2025)
 Figure 58. Novartis AG Revenue Growth Rate in Premenstrual Syndrome Treatment Business (2020-2025)
 Figure 59. Merck & Co., Inc. Revenue Growth Rate in Premenstrual Syndrome Treatment Business (2020-2025)
 Figure 60. Allergan plc Revenue Growth Rate in Premenstrual Syndrome Treatment Business (2020-2025)
 Figure 61. Mylan N.V. Revenue Growth Rate in Premenstrual Syndrome Treatment Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global PMS And Menstrual Health Supplements Market Research Report 2024
Global Pre Menstrual Syndrome Market Insights Forecast to 2030
Global Premenstrual Dysphoric Disorder PMDD Market Insights Forecast to 2030
Polycystic Ovarian Syndrome PCOS Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Phelan McDermid Syndrome PMS Market Research Report 2024
Global Premenstrual Syndrome Medicine Market Research Report 2025
Global Polycystic Ovary Syndrome PCOS Treatment Market Research Report 2024
Global Menopausal Hormone Therapy Market Research Report 2024
Global Menopause Drugs Market Insights Forecast to 2030
Global Menstrual Regulating Drug Market Research Report 2024
Global Cloud PMS Property Management System Market Research Report 2024
Irritable Bowel Syndrome Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Women s Health Market Research Report 2025
Global Medical Practice Management Software Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Medical Practice Management Software PMS Market Insights Forecast to 2030
Global Hotel PMS Market Research Report 2025
Global Medical Practice Management PMS Market Insights Forecast to 2030
Global Period Patch Market Research Report 2024
Irritable Bowel Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Migraine Treatment Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions